Articles by James C. Stolzenbach (4)

Efficacy and Safety of ABT-335 (Fenofibric Acid) in Combination with Rosuvastatin in Patients with Mixed Dyslipidemia: A Phase 3 Study

Peter H. Jones, Susan M. Buttler, Michael H. Davidson, Moti L. Kashyap, Maureen T. Kelly, Carolyn M. Setze, Darryl J. Sleep and James C. Stolzenbach

Journal of Clinical Lipidology 2 ( 3 ): 218 - 219 , 2008

Long-term safety and efficacy of fenofibric acid in combination with statin therapy for the treatment of patients with mixed dyslipidemia

Harold E. Bays, Peter H. Jones, Syed M. Mohiuddin, Maureen T. Kelly, Hsiaoming Sun, Carolyn M. Setze, Susan M. Buttler, Darryl J. Sleep and James C. Stolzenbach

Journal of Clinical Lipidology 2 ( 6 ): 426 - 435 , 2008

Efficacy and safety of fenofibric acid in combination with a statin in patients with mixed dyslipidemia: Pooled analysis of three phase 3, 12-week randomized, controlled studies

Peter H. Jones, Michael H. Davidson, Anne C. Goldberg, Carl J. Pepine, Maureen T. Kelly, Susan M. Buttler, Carolyn M. Setze, Aditya Lele, Darryl J. Sleep and James C. Stolzenbach

Journal of Clinical Lipidology 3 ( 2 ): 125 - 137 , 2009

Efficacy and Safety of Fenofibric Acid + Rosuvastatin Versus Rosuvastatin Alone in Patients With Mixed Dyslipidemia and Stage 3 Chronic Kidney Disease

Debra L. Weinstein, Laura A. Williams, Dawn M. Carlson, Maureen T. Kelly, James W. Blasetto, Kim M. Burns, Carolyn M. Setze, Aditya Lele and James C. Stolzenbach

Journal of Clinical Lipidology 6 ( 3 ): 269 - 270 , 2012

Do you have a suggestion for journals

Suggest Journal